Does Heterologous COVID-19 Vaccination Protect Against Seasonal Coronaviruses?
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
Researchers conducted a study to determine whether homologous COVID-19 vaccination increases in vitro neutralizing activity against seasonal human coronaviruses.
The American College of Physicians has released version 2 of their rapid, living practice points to summarize currently available evidence on the antibody response and natural immunity conferred by prior COVID-19 infection.
Researchers conducted a study that compared rapid treatment with a 7-day course of sofosbuvir-velpatasvir with usual compare in patients with hepatitis C virus infection who use injectable drugs.